1,259
Views
39
CrossRef citations to date
0
Altmetric
Original Articles

Efficacy and Safety of Saffron Supplementation: Current Clinical Findings

, , &

REFERENCES

  • Age-Related Eye Disease Study 2 Research Group. (2013). Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: The Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 309:2005–2015.
  • Agha-Hosseini, M., Kashani, L., Aleyaseen, A., Ghoreishi, A., Rahmanpour, H., et al. (2008). Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: A double-blind, randomised and placebo-controlled trial. BJOG. 115:515–519.
  • Ahmad, A. S., et al. (2005). Neuroprotection by crocetin in a hemi-parkinsonian rat model. Pharmacol. Biochem. Behav. 81:805–813.
  • Akhondzadeh Basti, A., Moshiri, E., Noorbala, A. A., Jamshidi, A. H., Abbasi, S. H., Akhondzadeh, S. (2007). Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: A pilot double-blind randomized trial. Prog. Neuropsychopharmacol. Biol. Psychiatry. 31:439–442.
  • Akhondzadeh, S., Fallah-Pour, H., Afkham, K., Jamshidi A. H., Khalighi-Cigaroud, F. (2004). Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial [ISRCTN45683816]. BMC Complement. Altern. Med. 4:12.
  • Akhondzadeh, S., Sabet, M. S., Harirchian, M. H., Togha, M., Cheraghmakani, H., et al. (2010a). Saffron in the treatment of patients with mild to moderate Alzheimer's disease: A 16-week, randomized and placebo-controlled trial. J. Clin. Pharm. Ther. 35:581–588.
  • Akhondzadeh, S., Shafiee Sabet, M., Harirchian, M. H., Togha, M., Cheraghmakani, H., et al. (2010b). A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease. Psychopharmacology (Berl). 207:637–643.
  • Akhondzadeh, S., et al. (2005). Crocus sativus L. in the treatment of mild to moderate depression: A double-blind, randomized and placebo-controlled trial. Phytother. Res. 19:148–151.
  • Asdaq, S. M., and Inamdar, M. N. (2010). Potential of Crocus sativus (saffron) and its constituent, crocin, as hypolipidemic and antioxidant in rats. Appl. Biochem. Biotechnol. 162:358–372.
  • Assimopoulou, A. N., Sinakos, Z., Papageorgiou, V. P. (2005). Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents. Phytother. Res. 19:997–1000.
  • Ayatollahi, H., Avan, A. O., Khajedaluee, M., Shahroodian, M., Hosseinzadeh, H. (2013). Effect of Crocus sativus L. (Saffron) on Coagulation and Anticoagulation Systems in Healthy Volunteers. Phytother. Res. Epub ahead of print.
  • Babu, Y. P., et al. (2012). Colchicine poisoning: A case report and review of literature. Med. Sci. Law. 52:205–206.
  • Bathaie, S. Z., and Mousavi, S. Z. (2010). New applications and mechanisms of action of saffron and its important ingredients. Crit. Rev. Food Sci. Nutr. 50:761–786.
  • Berger, F., et al. (2011). Saffron extract and trans-crocetin inhibit glutamatergic synaptic transmission in rat cortical brain slices. Neuroscience. 180:238–247.
  • Bharti, S., et al. (2012). Akt/GSK-3beta/eNOS phosphorylation arbitrates safranal-induced myocardial protection against ischemia-reperfusion injury in rats. Eur. J. Nutr. 51:719–727.
  • Ebrahim-Habibi, M. B., Amininasab, M., Ebrahim-Habibi, A., Sabbaghian, M., Nemat-Gorgani, M. (2010). Fibrillation of alpha-lactalbumin: Effect of crocin and safranal, two natural small molecules from Crocus sativus. Biopolymers. 93:854–865.
  • Falsini, B., et al. (2010). Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 51:6118–6124.
  • Feo, F., et al. (1997). Occupational allergy in saffron workers. Allergy. 52:633–641.
  • Fernandez-Sanchez, L., et al. (2012). Safranal, a saffron constituent, attenuates retinal degeneration in P23H rats. PLoS One. 7:e43074.
  • Fukui, H., Toyoshima, K., Komaki, R. (2011). Psychological and neuroendocrinological effects of odor of saffron (Crocus sativus). Phytomedicine. 18:726–730.
  • Georgiadou, G., Tarantilis, P. A., Pitsikas, N. (2012). Effects of the active constituents of Crocus Sativus L., crocins, in an animal model of obsessive-compulsive disorder. Neurosci. Lett. 528:27–30.
  • Geromichalos, G. D., Lamari, F. N., Papandreou, M. A., Trafalis, D. T., Margarity, M. (2012). Saffron as a source of novel acetylcholinesterase inhibitors: Molecular docking and in vitro enzymatic studies. J. Agric. Food Chem. 60:6131–6138.
  • Ghahghaei, A., Bathaie, S. Z., Kheirkhah, H., Bahraminejad, E. (2013). The protective effect of crocin on the amyloid fibril formation of AB peptide in vitro. Cell Mol. Biol. Lett. Epub ahead of print. Author: Please update reference Ghahghaei et al. (2013).
  • Gomez-Gomez, L., Feo-Brito, F., Rubio-Moraga, A., Galindo, P. A., Prieto, A., Ahrazem, O. (2010). Involvement of lipid transfer proteins in saffron hypersensitivity: Molecular cloning of the potential allergens. J. Invest. Allergol. Clin. Immunol. 20:407–412.
  • Gout, B., Bourges, C., Paineau-Dubreuil, S. (2010). Satiereal, a Crocus sativus L extract, reduces snacking and increases satiety in a randomized placebo-controlled study of mildly overweight, healthy women. Nutr. Res. 30:305–313.
  • He, S. Y., et al. (2005). Effect of crocin on experimental atherosclerosis in quails and its mechanisms. Life Sci. 77:907–921.
  • He, S. Y., Qian, Z. Y., Wen, N., Tang, F. T., Xu GL, Zhou, C. H. (2007). Influence of Crocetin on experimental atherosclerosis in hyperlipidamic-diet quails. Eur. J. Pharmacol. 554:191–195.
  • Heidary, M., Vahhabi, S., Reza Nejadi, J., Delfan, B., et al. (2008). Effect of saffron on semen parameters of infertile men. Urol. J. 5:255–259.
  • Himeno, H., and Sano, K. (1987). Synethesis of crocin, picrocorcin and safranal by saffron stigma-like structure proliferated in vitro. Agric. Biol. Chem. 9:2395–2400.
  • Hosseinzadeh, H., and Jahanian, Z. (2010). Effect of Crocus sativus L. (saffron) stigma and its constituents, crocin and safranal, on morphine withdrawal syndrome in mice. Phytother. Res. 24:726–730.
  • Hosseinzadeh, H., and Noraei, N. B. (2009). Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice. Phytother. Res. 23:768–774.
  • Hosseinzadeh, H., Ziaee, T., Sadeghi, A. (2008). The effect of saffron, Crocus sativus stigma, extract and its constituents, safranal and crocin on sexual behaviors in normal male rats. Phytomedicine. 15:491–495.
  • Javadi, B., Sahebkar, A., Emami, S. A. (2013). A survey on saffron in major islamic traditional medicine books. Iran. J. Basic. Med. Sci. 16:1–11.
  • Joukar, S., Ghasemipour-Afshar, E., Sheibani, M., Naghsh, N., Bashiri, A. (2013). Protective effects of saffron (Crocus sativus) against lethal ventricular arrhythmias induced by heart reperfusion in rat: A potential anti-arrhythmic agent. Pharm. Biol. 51:836–843.
  • Joukar, S., et al. (2010). The effect of saffron consumption on biochemical and histopathological heart indices of rats with myocardial infarction. Cardiovasc. Toxicol. 10:66–71.
  • Kanakis, C. D., Tarantilis, P. A., Tajmir-Riahi, H. A., Polissiou, M. G. (2007). Crocetin, dimethylcrocetin, and safranal bind human serum albumin: Stability and antioxidative properties. J. Agric. Food Chem. 55:970–977.
  • Karimi, E., et al. (2010). Evaluation of Crocus sativus L. stigma phenolic and flavonoid compounds and its antioxidant activity. Molecules. 15:6244–6256.
  • Kashani, L., et al. (2013). Saffron for treatment of fluoxetine-induced sexual dysfunction in women: Randomized double-blind placebo-controlled study. Hum. Psychopharmacol. 28:54–60.
  • Khalili, M., and Hamzeh, F. (2010). Effects of active constituents of Crocus sativus L., crocin on streptozocin-induced model of sporadic Alzheimer's disease in male rats. Iran Biomed. J. 14:59–65.
  • Khori, V., et al. (2012). Frequency-dependent electrophysiological remodeling of the AV node by hydroalcohol extract of Crocus sativus L. (saffron) during experimental atrial fibrillation: The role of endogenous nitric oxide. Phytother. Res. 26:826–832.
  • Kianbakht, S., and Ghazavi, A. (2011). Immunomodulatory effects of saffron: A randomized double-blind placebo-controlled clinical trial. Phytother. Res. 25:1801–1805.
  • Kuratsune, H., et al. (2010). Effect of crocetin from Gardenia jasminoides Ellis on sleep: A pilot study. Phytomedicine. 17:840–843.
  • Lechtenberg, M., et al. (2008). Quality and functionality of saffron: Quality control, species assortment and affinity of extract and isolated saffron compounds to NMDA and sigma1 (sigma-1) receptors. Planta. Med. 74:764–772.
  • Lee, I. A., Lee, J. H., Baek, N. I., Kim, D. H. (2005). Antihyperlipidemic effect of crocin isolated from the fructus of Gardenia jasminoides and its metabolite Crocetin. Biol. Pharm. Bull. 28:2106–2110.
  • Lev, E., and Amar, Z. (2008). “Fossils” of practical medical knowledge from medieval Cairo. J. Ethnopharmacol. 119:24–40.
  • Liu, Z., Xu, X. H., Liu, T. Y., Hong, Z. Y., Urade, Y. (2012). Safranal enhances non-rapid eye movement sleep in pentobarbital-treated mice. CNS Neurosci. Ther. 18:623–630.
  • Lucas, C. D., et al. (2001). The role of natural color additives in food allergy. Adv. Food Nutr. Res. 43:195–216.
  • Maccarone, R., Di Marco, S., Bisti, S. (2008). Saffron supplement maintains morphology and function after exposure to damaging light in mammalian retina. Invest. Ophthalmol. Vis. Sci.49:1254–1261.
  • Makri, O. E., Ferlemi, A. V., Lamari, F. N., Georgakopoulos, C. D. (2013). Saffron administration prevents selenite-induced cataractogenesis. Mol. Vis. 19:1188–1197.
  • Marangoni, D., Falsini, B., Piccardi, M., Ambrosio, L., Minnella, A. M., et al. (2013). Functional effect of Saffron supplementation and risk genotypes in early age-related macular degeneration: A preliminary report. J. Transl. Med. 11:228.
  • Martinez, F. V., Muñoz Pamplona, M. P., Urzaiz, A. G., García, E. C. (2007). Occupational airborne contact dermatitis from saffron bulbs. Contact Dermatitis. 57:284–285.
  • Masaki, M., Aritake, K., Tanaka, H., Shoyama, Y., Huang, Z. L. et al. (2012). Crocin promotes non-rapid eye movement sleep in mice. Mol. Nutr. Food Res. 56:304–308.
  • Mehdizadeh, R., Parizadeh, M. R., Khooei, A. R., Mehri. S,, Hosseinzadeh, H. (2013). Cardioprotective effect of saffron extract and safranal in isoproterenol-induced myocardial infarction in wistar rats. Iran J. Basic Med. Sci. 16:56–63.
  • Modabbernia, A., Sohrabi, H., Nasehi, A. A., Raisi, F., Saroukhani, S., et al. (2012). Effect of saffron on fluoxetine-induced sexual impairment in men: Randomized double-blind placebo-controlled trial. Psychopharmacology (Berl). 223:381–388.
  • Mohamadpour, A. H., Ayati, Z., Parizadeh, M. R., Rajbai, O., Hosseinzadeh, H. (2013). Safety Evaluation of Crocin (a constituent of saffron) Tablets in Healthy Volunteers. Iran J. Basic Med. Sci. 16:39–46.
  • Moneret-Vautrin, D. A., Morisset, M., Lemerdy, P., Croizier, A., Kanny, G. (2002). Food allergy and IgE sensitization caused by spices: CICBAA data (based on 589 cases of food allergy). Allerg. Immunol. (Paris). 34:135–140.
  • Moshiri, E., Basti, A. A., Noorbala, A. A., Jamshidi, A. H., Hesameddin Abbasi, S., Akhondzadeh, S. (2006). Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: A double-blind, randomized and placebo-controlled trial. Phytomedicine. 13:607–611.
  • Nahid, K., Fariborz, M., Ataolah, G., Solokian, S. (2009). The effect of an Iranian herbal drug on primary dysmenorrhea: A clinical controlled trial. J. Midwifery Womens Health. 54:401–404.
  • Ochiai, T., Shimeno, H., Mishima, K., Iwasaki, K., Fujiwara, M., et al. (2007). Protective effects of carotenoids from saffron on neuronal injury in vitro and in vivo. Biochim Biophys Acta. 1770:578–584.
  • Ohno, Y., Nakanishi, T., Umigai, N., Tsuruma, K., Shimazawa, M., Hara, H. (2012). Oral administration of crocetin prevents inner retinal damage induced by N-methyl-D-aspartate in mice. Eur. J. Pharmacol. 690:84–89.
  • Ordoudi, S. A., Befani, C. D., Nenadis, N., Koliakos, G. G., Tsimidou, M. Z. (2009). Further examination of antiradical properties of Crocus sativus stigmas extract rich in crocins. J. Agric. Food Chem. 57:3080–3086.
  • Pan, T. L., Wu, T. H., Wang, P. W., Leu, Y. L., Sintupisut, N., et al. (2013). Functional proteomics reveals the protective effects of saffron ethanolic extract on hepatic ischemia-reperfusion injury. Proteomics. Epub ahead of print.
  • Papandreou, M. A., Kanakis, C. D., Polissiou, M. G., Efthimiopoulos, S., Cordopatis, P., et al. (2006). Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents. J. Agric. Food Chem. 54:8762–8768.
  • Pfander, H., and Schurtenberger, H. (1982). Biosynthesis of C20-Carotenoids in Crocus Sativus. Phytochemistry. 21:4.
  • Pfister, S. M., Meyer, P., Steck, A., Pfander, H. (1996). Isolation and Structure Elucidation of Carotenoid-Glycosyl Esters in Gardenia Fruits (Gardenia-Jasminoides Ellis) and Saffron ( Crocus-Sativus Linne). J. Agric. Food Chem. 44:4.
  • Piccardi, M., Marangoni, D., Minnella. A,M,, Savastano, M. C., Valentini, P., et al. (2012). A longitudinal follow-up study of saffron supplementation in early age-related macular degeneration: Sustained benefits to central retinal function. Evid. Based Complement. Alternat. Med. 2012:429124.
  • Pitsikas, N., Boultadakis, A., Georgiadou, G., Tarantilis, P. A., Sakellaridis, N. (2008). Effects of the active constituents of Crocus sativus L., crocins, in an animal model of anxiety. Phytomedicine. 15:1135–1139.
  • Pitsikas, N., and Sakellaridis, N. (2006). Crocus sativus L. extracts antagonize memory impairments in different behavioural tasks in the rat. Behav. Brain Res. 173:112–115.
  • Purushothuman, S., Nandasena. C,, Peoples, C. L., El Massri, N., Johnstone, D. M., et al. (2013). Saffron pre-treatment offers neuroprotection to nigral and retinal dopaminergic cells of MPTP-Treated mice. J. Parkinsons Dis. 3:77–83.
  • Radu, R. A., Yuan, Q., Hu, J., Peng, J. H., Lloyd, M., et al. (2008). Accelerated accumulation of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies following Vitamin A supplementation. Invest. Ophthalmol. Vis. Sci. 49:3821–3829.
  • Razavi, B. M., Hosseinzadeh, H., Abnous, K., Imenshahidi, M. (2013). Protective effect of crocin on diazinon induced cardiotoxicity in rats in subchronic exposure. Chem. Biol. Interact. 203:547–555.
  • Safarinejad, M. R., Shafiei, N., Safarinejad, S. (2010). An open label, randomized, fixed-dose, crossover study comparing efficacy and safety of sildenafil citrate and saffron (Crocus sativus Linn.) for treating erectile dysfunction in men naive to treatment. Int. J. Impot. Res. 22:240–250.
  • Safarinejad, M. R., Shafiei, N., Safarinejad, S. (2011). A prospective double-blind randomized placebo-controlled study of the effect of saffron (Crocus sativus Linn.) on semen parameters and seminal plasma antioxidant capacity in infertile men with idiopathic oligoasthenoteratozoospermia. Phytother. Res. 25:508–516.
  • Samarghandian, S., Borji, A., Delkhosh, M. B., Samini, F. (2013). Safranal treatment improves hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats. J. Pharm. Pharm. Sci. 16:352–362.
  • Sanocka, D., Miesel, R., Jedrzejczak, P., Chełmonska-Soyta, A. C., Kurpisz, M. (1997). Effect of reactive oxygen species and the activity of antioxidant systems on human semen; association with male infertility. Int. J. Androl. 20:255–264.
  • Schmidt, M., Betti, G., Hensel, A. (2007). Saffron in phytotherapy: Pharmacology and clinical uses. Wien Med. Wochenschr. 157:315–319.
  • Shamsa, A., et al. (2009). Evaluation of Crocus sativus L. (saffron) on male erectile dysfunction: A pilot study. Phytomedicine. 16:690–693.
  • Sheng, L., Qian, Z., Zheng, S., Xi, L. (2006). Mechanism of hypolipidemic effect of crocin in rats: Crocin inhibits pancreatic lipase. Eur. J. Pharmacol. 543:116–122.
  • Shirali, S., Zahra Bathaie, S., Nakhjavani, M. (2013). Effect of crocin on the insulin resistance and lipid profile of streptozotocin-induced diabetic rats. Phytother. Res. 27:1042–1047.
  • Tamaddonfard, E., Farshid, A. A., Asri-Rezaee, S., Javadi, S., Khosravi, V., et al. (2013). Crocin improved learning and memory impairments in streptozotocin-induced diabetic rats. Iran. J. Basic Med. Sci. 16:91–100.
  • Tang, F. T., Qian, Z. Y., Liu, P. Q., Zheng, S. G., He, S. Y., et al. (2006). Crocetin improves endothelium-dependent relaxation of thoracic aorta in hypercholesterolemic rabbit by increasing eNOS activity. Biochem. Pharmacol. 72:558–565.
  • Tarantilis, P. A., and Polissiou, M. G. (1997). Isolation and Identification of the Aroma Components from Saffron (Crocus savitus). J. Agric. Food Chem. 45:4.
  • Verma, S. K., and Bordia, A. (1998). Antioxidant property of Saffron in man. Indian J. Med. Sci. 52:205–207.
  • Winterhalter, P., and Straubinger, M. (2001). Saffron - renewed interest in an ancient spice. Food Rev. Int. 16:21.
  • Wuthrich, B., Schmid-Grendelmeyer, P., Lundberg, M. (1997). Anaphylaxis to saffron. Allergy. 52:476–477.
  • Xuan, B., Zhou, Y. H., Li, N., Min, Z. D., Chiou, G. C. (1999). Effects of crocin analogs on ocular blood flow and retinal function. J. Ocul. Pharmacol. Ther. 15:143–152.
  • Yamauchi, M., Tsuruma, K., Imai, S., Nakanishi, T., Umigai, N., et al. (2011). Crocetin prevents retinal degeneration induced by oxidative and endoplasmic reticulum stresses via inhibition of caspase activity. Eur. J. Pharmacol. 650:110–119.
  • Yan, J., Qian, Z., Sheng, L., Zhao, B., Yang, L., et al. (2010). Effect of crocetin on blood pressure restoration and synthesis of inflammatory mediators in heart after hemorrhagic shock in anesthetized rats. Shock. 33:83–87.
  • Zhang, Z., et al. (2013). Role of saffron and its constituents on cancer chemoprevention. Pharm. Biol. 51:920–924.
  • Zheng, S., Qian, Z., Sheng, L., Wen, N. (2006). Crocetin attenuates atherosclerosis in hyperlipidemic rabbits through inhibition of LDL oxidation. J. Cardiovasc. Pharmacol. 47:70–76.
  • Zheng, S., Qian, Z., Tang, F., Sheng, L. (2005). Suppression of vascular cell adhesion molecule-1 expression by crocetin contributes to attenuation of atherosclerosis in hypercholesterolemic rabbits. Biochem. Pharmacol. 70:1192–1199.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.